Article info
PDFBrief communication
SARS-CoV-2 vaccines in patients with SLE
- Correspondence to Dr Anca D Askanase; ada20{at}cumc.columbia.edu
Citation
SARS-CoV-2 vaccines in patients with SLE
Publication history
- Received January 15, 2021
- Revision received February 11, 2021
- Accepted February 20, 2021
- First published March 8, 2021.
Online issue publication
July 06, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.